- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Healthy high growth potential
Taiwanese Pharmaceuticals & Biotech Healthy high growth potential
Results
4
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
4 companies
PharmaEssentia
Market Cap: NT$550.3b
A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.
6446
NT$1,335.00
7D
23.6%
1Y
224.1%
Bora Pharmaceuticals
Market Cap: NT$54.1b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$424.50
7D
12.3%
1Y
-40.2%
Caliway Biopharmaceuticals
Market Cap: NT$168.9b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$108.50
7D
6.4%
1Y
-10.7%
Medigen Vaccine Biologics
Market Cap: NT$17.1b
A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.
6547
NT$52.10
7D
14.0%
1Y
21.9%